Regulatory labels and indication-specific trials drive prescribing, monitoring, and coverage, and GLP-1 medications accounted for 45% of the total diabetes drug market in 2023, making label strategy a core clinical and payer lever
Outcomes hinge on catechin dose, whether the product contains caffeine, and extract bioavailability
With regards to the efficacy of the different types of GLP-1RA, the sample size was also too limited to allow for further sub-analysis
Your body absorbs up to three times more B12 from dairy foods than from other sources, making it easier to get your fill from less food
Novo said its competitor compared the highest approved doses of its medicines for obesity and type-2 diabetes with lower doses of Novo Nordisk's, while omitting newer, higher-dose options